Hepatitis C: epidemiology, diagnosis, natural history and therapy.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Contributions to Nephrology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000332374PMID 22310776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Introduction and comments on EASL clinical practice guidelines: management of hepatitis C virus infection].

  2011cited by this paper
• Boceprevir for previously treated chronic HCV genotype 1 infection.

  2011cited by this paper
• The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report

  2010cited by this paper
• Telaprevir for previously treated chronic HCV infection.

  2010cited by this paper
• Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection.

  2010cited by this paper
• Hepatocellular carcinoma: a global view

  2010cited by this paper
• Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.

  2010cited by this paper
• Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

  2009cited by this paper
• The global burden of hepatitis C

  2009cited by this paper
• Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

  2009cited by this paper
• Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.

  2009cited by this paper
• Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C

  2008cited by this paper
• Acute hepatitis C: current status and remaining challenges.

  2008cited by this paper
• Hepatitis C genotype 4: What we know and what we don't yet know

  2008cited by this paper
• The changing epidemiology of hepatitis C virus infection in Europe.

  2008cited by this paper
• Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha

  2007cited by this paper
• Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia.

  2006cited by this paper
• Global epidemiology of hepatitis C virus infection.

  2005cited by this paper
• Peginterferon α-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response

  2005cited by this paper
• The natural history of hepatitis C.

  2004cited by this paper
• Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

  2004cited by this paper
• 505 The influence of cumulative exposure to combination peginterferon alfa-2A (40 KD) (Pegasys) and ribavirin on sustained virological response (SVR) rates in patients with genotype 1 chronic hepatitis C

  2004cited by this paper
• Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection

  2003cited by this paper
• Early virologic response to treatment with peginterferon alfa‐2b plus ribavirin in patients with chronic hepatitis C

  2003cited by this paper
• Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

  2002cited by this paper
• Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.

  2000cited by this paper
• Impact of interferon alfa‐2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C

  2000cited by this paper
• Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group.

  1998cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis

  2024cites this paper
• Antimicrobial peptides: natural or synthetic defense peptides against HBV and HCV infections

  2022cites this paper
• Prevalence and Risk Factors Associated with Hepatitis B and Hepatitis C Infections among Patients Undergoing Hemodialysis: A Single-Centre Study in Somalia

  2021cites this paper
• JUDICIALIZAÇÃO DE MEDICAMENTOS PARA TRATAMENTO DA HEPATITE C NO ESTADO DO RIO GRANDE DO SUL, BRASIL

  2021cites this paper
• The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: A systematic review and meta-analysis

  2021cites this paper
• Perfil epidemiológico de pacientes com Hepatite C no componente especializado da assistência farmacêutica do Piauí

  2020cites this paper
• Infection to Hepatitis C virus (HCV) is one of the critical health problems worldwide. HCV infection is one of the main causes of chronic viral hepatitis, hepatocellular carcinoma and also cirrhosis. HCV also is the leading reason for liver

  2020cites this paper
• Mother-to-child transmission of hepatitis B and C virus: review of the epidemiology and current treatment options

  2018cites this paper
• Association between human leucocyte antigen-DO polymorphisms and interferon/ribavirin treatment response in hepatitis C virus type 1 infection in Chinese population: a prospective study

  2018cites this paper
• GP205, a new hepatitis C virus NS3/4A protease inhibitor, displays higher metabolic stability in vitro and drug exposure in vivo

  2018cites this paper
• Association between alcohol consumption and injection and sexual risk behaviors among people who inject drugs in rural Puerto Rico.

  2017cites this paper
• New Epidemiologic Data Regarding Hepatitis C Virus Infection in Romania.

  2017cites this paper
• Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics

  2017cites this paper
• Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry

  2017cites this paper
• The value of real world data in healthcare decision-making : practical applications using observational data from the National Hepatitis C Treatment Registry

  2017influential citation
• Occult Hepatitis C Infection Among Hemodialysis Patients: A Prevalence Study.

  2017cites this paper
• Knowledge, Attitudes, and Practices of Health-Care Workers About Viral Hepatitis B and C in South Kivu.

  2017cites this paper
• Do disparities between populations in randomized controlled trials and the real world lead to differences in outcomes?

  2017cites this paper
• Dental Problems Associated with Hepatitis C Infection: A Report from Iran

  2016cites this paper
• Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus.

  2016cites this paper
• Charge neutralization as the major factor for the assembly of nucleocapsid-like particles from C-terminal truncated hepatitis C virus core protein

  2016cites this paper
• Effect of D168V mutation in NS3/4A HCV protease on susceptibilities of faldaprevir and danoprevir.

  2016cites this paper
• Polymorphisms and resistance mutations of hepatitis C virus on sequences in the European hepatitis C virus database

  2016cites this paper
• Direct costs of interferon‐based and interferon‐free direct‐acting antiviral regimens for the treatment of chronic hepatitis C infection

  2016cites this paper
• Hepatitis C Virus Genotype Distribution in Kermanshah Province, Western Iran

  2016cites this paper
• Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.

  2015cites this paper
• Resilience in Organ Transplantation: An Application of the Connor–Davidson Resilience Scale (CD–RISC) With Liver Transplant Candidates

  2015cites this paper
• Correlation between METAVIR scores and Raman spectroscopy in liver lesions induced by hepatitis C virus: a preliminary study

  2015cites this paper
• Effect of Oral Administration of Dietary Antioxidant Supplements in Patients with Chronic Hepatitis C

  2015cites this paper
• Pegylated Interferon Mono‐Therapy of Chronic Hepatitis C in the Dialysis Population: Systematic Review and Meta‐Analysis

  2015cites this paper
• Treatment of hepatitis C-related kidney disease

  2015cites this paper
• Management of colon cancer in patients with cirrhosis: A review.

  2015cites this paper
• Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C

  2015cites this paper
• A Conserved Inhibitory Mechanism of a Lycorine Derivative against Enterovirus and Hepatitis C Virus

  2015cites this paper
• Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis

  2015cites this paper
• Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at Kidney Centre in a tertiary health facility in Maiduguri, Nigeria

  2014cites this paper
• Treatment of hepatitis C after kidney transplant: A pooled analysis of observational studies

  2014cites this paper
• Hepatitis C Virus; Its Implication for Endodontists

  2014cites this paper
• Recent Advances on Hepatitis C Virus in Dialysis Population

  2014cites this paper
• Acute Tubular Necrosis Following Interferon-Based Therapy for Hepatitis C: Case Study with Literature Review

  2014cites this paper
• Knowledge, attitude, and performance of medical staff of teaching healthcare settings about hepatitis B and C in Isfahan, Iran

  2014cites this paper
• Histological and Clinical Characteristics of Patients with Chronic Hepatitis C and Persistently Normal Alanine Aminotransferase Levels

  2014cites this paper
• Modulation of hepatitis C virus core DNA vaccine immune responses by co-immunization with CC-chemokine ligand 20 (CCL20) gene as immunoadjuvant

  2014cites this paper
• Resistance to hepatitis C virus protease inhibitors.

  2014cites this paper
• Association of higher-risk alcohol consumption with injecting paraphernalia sharing behaviours in intravenous drug users

  2014cites this paper
• Genotypic and Phenotypic Analyses of Hepatitis C Virus Variants Observed in Clinical Studies of VX-222, a Nonnucleoside NS5B Polymerase Inhibitor

  2014cites this paper
• Acute Allograft Rejection following Interferon Therapy for Hepatitis C in Recipients who have Returned to Dialysis after Kidney Transplant Failure: Case Study

  2014cites this paper
• Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta‐analysis of clinical studies

  2014cites this paper
• Effect of zinc supplementation on viral response in patients with chronic hepatitis C and Beta thalassemia major, a pilot study.

  2014cites this paper
• Hepatitis C virus infection and glomerular disease.

  2014cites this paper
• [Investigation of hepatitis C virus genotype distribution in patients with chronic hepatitis C infections in Antalya Training and Research Hospital, Turkey].

  2014cites this paper
• The Unravelled Link between Chronic Kidney Disease and Hepatitis C Infection

  2014cites this paper
• Update to hepatitis C review.

  2014cites this paper
• MicroRNA‐155 and microRNA‐196b: promising biomarkers in hepatitis C virus infection?

  2014cites this paper
• MicroRNA-155 and biomarkers in hepa Reviews in

  2014cites this paper
• Oral Conditions Associated with Hepatitis C Virus Infection

  2013cites this paper
• Recipient ineligibility after liver transplantation assessment: a single centre experience.

  2013cites this paper
• Variation of Transaminases, HCV-RNA Levels and Th1/Th2 Cytokine Production during the Post-Partum Period in Pregnant Women with Chronic Hepatitis C

  2013cites this paper
• Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors.

  2013cites this paper
• Comparison of the Prevalence of Psychiatric Co-Morbidities in Hepatitis C Patients and Hepatitis B Patients in Saudi Arabia

  2013cites this paper
• Association of Hepatitis C With Markers of Hemostasis In HIV-Infected and Uninfected Women in the Women's Interagency HIV Study (WIHS)

  2013cites this paper
• Understanding the biological context of NS5A-host interactions in HCV infection: a network-based approach.

  2013cites this paper
• Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.

  2013cites this paper
• Could near-infrared Raman spectroscopy be correlated with the METAVIR scores in liver lesions induced by hepatitis C virus?

  2013cites this paper
• СоЦиаЛЬнЫе аСПеКТЫ СМерТноСТи оТ ХрониЧеСКиХ ВирУСнЫХ ГеПаТиТоВ Среди СеЛЬСКоГо и ГородСКоГо наСеЛения аЛТаЙСКоГо Края

  2013cites this paper
• Hepatitis C treatment in patients with kidney disease.

  2013cites this paper
• Cellular re- and de-programming by microenvironmental memory: why short TGF-β1 pulses can have long effects

  2013cites this paper
• A combined proteomics and computational approach provides a better understanding of HCV-induced liver disease

  2012cites this paper
• Computational Analysis of RNAi Screening Data to Identify Host Factors Involved in Viral Infection and to Characterize Protein-Protein Interactions

  2012cites this paper
• Historia natural de la hepatitis por virus C (VHC)

  2012cites this paper
• Influence of Healthcare-Associated Factors on the Efficacy of Hepatitis C Therapy

  2012cites this paper
• zur Erlangung der Doktorwurde der Naturwissenschaftlich-Mathematischen Gesamtfakultat der Ruprecht-Karls-Universitat Heidelberg

  2012cites this paper
• Hepatitis C Virus Infection and Dialysis: 2012 Update

  2012cites this paper